Published in Infect Immun on January 01, 1983
Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev (2000) 4.59
A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen. Infect Immun (1985) 2.81
A set of two monoclonal antibodies specific for the cell surface-exposed 39K major outer membrane protein of Haemophilus influenzae type b defines all strains of this pathogen. Infect Immun (1983) 1.95
Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5. Infect Immun (1987) 1.94
Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b. Infect Immun (1987) 1.82
Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun (1986) 1.79
Protection of infant rats from Haemophilus influenzae type b infection by antiserum to purified outer membrane protein a. Infect Immun (1987) 1.75
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. Nucleic Acids Res (1984) 1.60
Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J Clin Invest (1992) 1.45
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect Immun (1991) 1.42
Haemophilus influenzae type b conjugate vaccines. Immunology (2004) 1.37
Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun (2000) 1.36
Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Infect Immun (1984) 1.34
Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197. J Clin Invest (1985) 1.25
Production of glycoprotein vaccines in Escherichia coli. Microb Cell Fact (2010) 1.23
Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components. Infect Immun (1993) 1.21
Cloning and surface expression in Escherichia coli of a structural gene encoding a surface protein of Haemophilus influenzae type b. Infect Immun (1985) 1.21
Immunogenic proteins in cell-free culture supernatants of Haemophilus influenzae type b. Infect Immun (1984) 1.15
Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun (1984) 1.12
Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc Natl Acad Sci U S A (2012) 1.09
Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine. Infect Immun (1985) 1.09
Isolation and characterization of Corynebacterium diphtheriae nontandem double lysogens hyperproducing CRM197. Appl Environ Microbiol (1983) 1.08
Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun (1994) 1.05
CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect Immun (2000) 1.05
Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex. Infect Immun (1992) 1.00
On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines. Proc Natl Acad Sci U S A (2002) 0.99
Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens. Postgrad Med J (2001) 0.95
Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates. Infect Immun (1993) 0.95
Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine. Infect Immun (1991) 0.93
MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine. Infect Immun (1997) 0.91
Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b. Infect Immun (2004) 0.87
Population subdivision and the detection of recombination in non-typable Haemophilus influenzae. Microbiology (2012) 0.82
Distinct pattern of antibody reactivity with oligomeric or polymeric forms of the capsular polysaccharide of Haemophilus influenzae type b. Infect Immun (1991) 0.81
Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity. Clin Vaccine Immunol (2006) 0.79
Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering. Open Biol (2015) 0.78
Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine. Infect Immun (2016) 0.78
Rationale and prospects for novel pneumococcal vaccines. Hum Vaccin Immunother (2016) 0.77
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma. Pharmaceuticals (Basel) (2011) 0.75
Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol (1972) 40.51
Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med (1980) 5.32
Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics (1977) 4.64
Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res (1973) 3.89
An immunological study of the diphtheria toxin molecule. Immunochemistry (1972) 3.48
Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33
Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J Immunol (1981) 3.04
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan. J Biol Chem (1975) 2.30
Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization. Arch Biochem Biophys (1977) 2.09
Long-term sequelae of Hemophilus influenzae meningitis. Pediatrics (1972) 1.87
Reconstitution of diphtheria toxin from two nontoxic cross-reacting mutant proteins. Science (1972) 1.82
Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B. J Immunol (1978) 1.79
Carrier-priming leads to hapten-specific suppression. Nature (1980) 1.69
Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b. Infect Immun (1977) 1.40
CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : XII. THE IMMUNOLOGICAL PROPERTIES OF AN ARTIFICIAL ANTIGEN CONTAINING CELLOBIURONIC ACID. J Exp Med (1938) 1.33
Augmented anti-S 3 antibody responses to an S 3 -protein conjugate. J Immunol (1971) 1.27
Distinct functions of monoclonal IgG antibody depend on antigen-site specificities. J Exp Med (1979) 1.12
Immune response of neonates to pneumococcal polysaccharide-protein conjugate. Immunology (1982) 1.05
Spatial requirements between haptenic and carrier determinants for T-dependent antibody responses. J Exp Med (1978) 0.94
Immune response to chemically modified antigens. Prog Allergy (1977) 0.89
Glycosylation of Escherichia coli L-asparaginase. J Biol Chem (1977) 0.86
RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol (1999) 8.07
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans (2002) 6.08
Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol (2000) 5.99
mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev (1993) 5.94
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell (1991) 5.65
Spontaneous tandem genetic duplications in Salmonella typhimurium arise by unequal recombination between rRNA (rrn) cistrons. Proc Natl Acad Sci U S A (1981) 4.85
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med (1999) 4.66
TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J (2000) 4.41
Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol (1997) 4.28
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut (2009) 4.06
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet (2001) 3.96
Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol (2013) 3.72
A new kind of informational suppression in the nematode Caenorhabditis elegans. Genetics (1989) 3.69
Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33
SMG-2 is a phosphorylated protein required for mRNA surveillance in Caenorhabditis elegans and related to Upf1p of yeast. Mol Cell Biol (1999) 3.18
General practitioners and alternative medicine. J R Coll Gen Pract (1987) 3.10
Life and death in the cytoplasm: messages from the 3' end. Curr Opin Genet Dev (1997) 3.01
Activation of a transposable element in the germ line but not the soma of Caenorhabditis elegans. Nature (1987) 3.00
The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol Cell (2000) 2.97
Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities. J Biol Chem (1996) 2.89
Electron microscope observations on compounds 48-80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules. J Cell Biol (1971) 2.88
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood (1996) 2.62
Increased rate of tuberculin skin test conversion among workers at a university hospital. Infect Control Hosp Epidemiol (1992) 2.60
Inhibition of protein synthesis by spectinomycin. Science (1965) 2.54
What are safe levels of alcohol consumption? Br Med J (Clin Res Ed) (1984) 2.54
Unproductively spliced ribosomal protein mRNAs are natural targets of mRNA surveillance in C. elegans. Genes Dev (2000) 2.52
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A (1992) 2.38
Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b. J Pediatr (1972) 2.33
Transposition of Tc1 in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1985) 2.33
Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun (1991) 2.22
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun (2001) 2.19
The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc Natl Acad Sci U S A (1995) 2.15
Development of executive functions through late childhood and adolescence in an Australian sample. Dev Neuropsychol (2001) 2.14
A selection for myosin heavy chain mutants in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1984) 2.10
Safe limits of drinking: general practitioners' views. Br Med J (Clin Res Ed) (1985) 2.06
Supercoiling in closed circular DNA: dependence upon ion type and concentration. Biochemistry (1978) 2.01
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Cell proteins TIA-1 and TIAR interact with the 3' stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication. J Virol (2002) 1.98
Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res (1993) 1.95
Community general practitioner. Lancet (1985) 1.94
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Effect of spectinomycin on polypeptide synthesis in extracts of Escherichia coli. J Mol Biol (1967) 1.93
Site-selected insertion of the transposon Tc1 into a Caenorhabditis elegans myosin light chain gene. Mol Cell Biol (1993) 1.92
smg-7 is required for mRNA surveillance in Caenorhabditis elegans. Genetics (1999) 1.90
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88
G proteins are required for spatial orientation of early cell cleavages in C. elegans embryos. Cell (1996) 1.86
The AAPPQ revisited: the measurement of general practitioners' attitudes to alcohol problems. Br J Addict (1987) 1.85
Insertion and excision of Caenorhabditis elegans transposable element Tc1. Mol Cell Biol (1988) 1.80
The gene structures of spontaneous mutations affecting a Caenorhabditis elegans myosin heavy chain gene. Genetics (1985) 1.79
Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B. J Immunol (1978) 1.79
RNA-binding protein TIAR is essential for primordial germ cell development. Proc Natl Acad Sci U S A (1998) 1.76
Death, autoantigen modifications, and tolerance. Arthritis Res (2000) 1.75
Malignant pleural effusion of multiple myeloma: prognostic factors and outcome. Leuk Lymphoma (2005) 1.75
Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J Exp Med (1995) 1.75
Advances in the molecular genetic analysis of the flax-flax rust interaction. Annu Rev Phytopathol (1997) 1.72
BOLD based functional MRI at 4 Tesla includes a capillary bed contribution: echo-planar imaging correlates with previous optical imaging using intrinsic signals. Magn Reson Med (1995) 1.71
Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1996) 1.71
Sequential exocytosis of storage granules during antigen-induced histamine release from sensitized rat mast cells in vitro. An electron microscopic study. Acta Physiol Scand (1973) 1.70
Learning by internal medicine residents: differences and similarities of perceptions by residents and faculty. J Gen Intern Med (1995) 1.69
Managing alcohol problems in general practice. Br Med J (Clin Res Ed) (1985) 1.69
Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem (1999) 1.69
Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child (2000) 1.67
The Tc3 family of transposable genetic elements in Caenorhabditis elegans. Genetics (1989) 1.66
Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med (1997) 1.66
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Human interferon-gamma is internalized and degraded by cultured fibroblasts. J Biol Chem (1983) 1.63
Structures of spontaneous deletions in Caenorhabditis elegans. Mol Cell Biol (1988) 1.61
Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B. Clin Immunol Immunopathol (1973) 1.60
Functions of the myosin ATP and actin binding sites are required for C. elegans thick filament assembly. Cell (1990) 1.59
Phosphatidate and oxidized fatty acids are calcium ionophores. Studies employing arsenazo III in liposomes. J Biol Chem (1981) 1.59
mRNA surveillance mitigates genetic dominance in Caenorhabditis elegans. Mol Gen Genet (1998) 1.58
A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. Arthritis Rheum (2001) 1.57
Randomized controlled trial of general practitioner intervention in women with excessive alcohol consumption. Drug Alcohol Rev (1991) 1.57
Structure, tissue distribution and genomic organization of the murine RRM-type RNA binding proteins TIA-1 and TIAR. Nucleic Acids Res (1996) 1.56
Specific binding of 125I-human interferon-gamma to high affinity receptors on human fibroblasts. J Biol Chem (1982) 1.54
Haemophilus influenzae disease in Alaskan Eskimos: characteristics of a population with an unusual incidence of invasive disease. Lancet (1981) 1.53
Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur J Immunol (1996) 1.51
WHO Europe evidence based recommendations on the treatment of tobacco dependence. Tob Control (2002) 1.51
Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults. J Immunol (1985) 1.48
Structural similarity between Fc receptors and T cell receptors. Expression of the gamma-subunit of Fc epsilon RI in human T cells, natural killer cells and thymocytes. J Immunol (1991) 1.44
Is alcohol a carcinogenic risk? Br J Addict (1990) 1.43
Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol (1991) 1.43
Myosin heavy-chain mutations that disrupt Caenorhabditis elegans thick filament assembly. Genes Dev (1988) 1.43
Misonidazole-a drug for trial in radiotherapy and oncology. Int J Radiat Oncol Biol Phys (1979) 1.41
Delivering educational programs via telephone: teleconferencing. Vet Hum Toxicol (1984) 1.40
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1984) 1.40
Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b. Infect Immun (1977) 1.40
Efficacy of metered-dose inhaler administration of albuterol in intubated infants. Chest (1997) 1.40
Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. JAMA (1995) 1.40
Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys (2001) 1.40
Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum (1998) 1.39
Multiple carpo-metacarpal dislocations. J Hand Surg Br (1989) 1.39
The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum. Br J Cancer Suppl (1978) 1.38
Mode of activation of hippocampal pyramidal cells by excitatory synapses on dendrites. Exp Brain Res (1966) 1.38
Management of large-scale disasters. S Afr Med J (1993) 1.38